164 related articles for article (PubMed ID: 11773597)
21. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.
Bouchard C; Marquardt J; Brás A; Medema RH; Eilers M
EMBO J; 2004 Jul; 23(14):2830-40. PubMed ID: 15241468
[TBL] [Abstract][Full Text] [Related]
22. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
[TBL] [Abstract][Full Text] [Related]
23. Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt.
Janes SM; Ofstad TA; Campbell DH; Watt FM; Prowse DM
J Cell Sci; 2004 Aug; 117(Pt 18):4157-68. PubMed ID: 15316080
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
25. c-Myc induces the expression and activity of ornithine decarboxylase.
Wagner AJ; Meyers C; Laimins LA; Hay N
Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793
[TBL] [Abstract][Full Text] [Related]
26. Anti-growth factor activities of benzothiophenes in human breast cancer cells.
Freiss G; Galtier F; Puech C; Aknin C; Maudelonde T; Chalbos D; Vignon F
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):451-60. PubMed ID: 15876410
[TBL] [Abstract][Full Text] [Related]
27. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
[TBL] [Abstract][Full Text] [Related]
28. Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts.
Mehmet H; Littlewood TD; Sinnett-Smith J; Moore JP; Evan GI; Rozengurt E
Cell Growth Differ; 1997 Feb; 8(2):187-93. PubMed ID: 9040940
[TBL] [Abstract][Full Text] [Related]
29. Myc drives apoptosis in PC12 cells in the absence of Max.
Wert M; Kennedy S; Palfrey HC; Hay N
Oncogene; 2001 Jun; 20(28):3746-50. PubMed ID: 11439337
[TBL] [Abstract][Full Text] [Related]
30. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways.
Dhandapani KM; Wade FM; Mahesh VB; Brann DW
Endocrinology; 2005 Jun; 146(6):2749-59. PubMed ID: 15746252
[TBL] [Abstract][Full Text] [Related]
31. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
32. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
33. Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies.
Shin I; Edl J; Biswas S; Lin PC; Mernaugh R; Arteaga CL
Cancer Res; 2005 Apr; 65(7):2815-24. PubMed ID: 15805282
[TBL] [Abstract][Full Text] [Related]
34. Chronic activation of protein kinase Bbeta/Akt2 leads to multinucleation and cell fusion in human epithelial kidney cells: events associated with tumorigenesis.
Jin J; Woodgett JR
Oncogene; 2005 Aug; 24(35):5459-70. PubMed ID: 16007218
[TBL] [Abstract][Full Text] [Related]
35. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.
Gregory MA; Xiao Q; Cornwall GA; Lutterbach B; Hann SR
Oncogene; 2000 Oct; 19(42):4886-95. PubMed ID: 11039906
[TBL] [Abstract][Full Text] [Related]
36. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
Caruana G; Cambareri AC; Ashman LK
Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
[TBL] [Abstract][Full Text] [Related]
37. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER.
McCarthy SA; Aziz N; McMahon M
Methods Mol Biol; 1997; 85():137-51. PubMed ID: 9276321
[No Abstract] [Full Text] [Related]
38. Modulation of c-Myc activity and apoptosis in vivo.
Alarcon RM; Rupnow BA; Graeber TG; Knox SJ; Giaccia AJ
Cancer Res; 1996 Oct; 56(19):4315-9. PubMed ID: 8813114
[TBL] [Abstract][Full Text] [Related]
39. The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.
van Dam H; Offringa R; Smits AM; Bos JL; Jones NC; van der Eb AJ
Oncogene; 1989 Oct; 4(10):1207-12. PubMed ID: 2529466
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 is a potent regulator of JE and KC gene expression in quiescent BALB/c fibroblasts.
Hall DJ; Brownlee C; Stiles CD
J Cell Physiol; 1989 Oct; 141(1):154-9. PubMed ID: 2506194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
